Items where authors include "De Lorenzis, E."

Article

Di Donato, S. orcid.org/0000-0003-1256-0761, Ross, R., Karanth, R. et al. (7 more authors) (2025) Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis. Arthritis & Rheumatology. ISSN 2326-5191

Ross, R.L., Caballero-Ruiz, B., Clarke, E.L. et al. (11 more authors) (2024) Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS). Rheumatology. keae698. ISSN 1462-0324

Wasson, C.W., De Lorenzis, E., Clavane, E.M. et al. (14 more authors) (2024) The β-Secretase BACE1 Drives Fibroblast Activation in Systemic Sclerosis through the APP/β-Catenin/Notch Signaling Axis. Journal of Investigative Dermatology, 144 (10). pp. 2197-2210. ISSN 0022-202X

De Lorenzis, E., Natalello, G., Pellegrino, G. et al. (29 more authors) (2024) Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. keae532. ISSN 1462-0324

Denton, C.P., De Lorenzis, E., Roblin, E. et al. (27 more authors) (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology. keae394. ISSN 1462-0324

Denton, C.P., De Lorenzis, E., Roblin, E. et al. (27 more authors) (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary. Rheumatology. keae390. ISSN 1462-0324

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Mor, A., Ross, R.L. et al. (4 more authors) (2024) Serum CCL24 as a biomarker of fibrotic and vascular disease severity in Systemic Sclerosis. Arthritis Care & Research, 76 (9). pp. 1269-1277. ISSN 2151-464X

De Lorenzis, E., Del Galdo, F., Natalello, G. et al. (10 more authors) (2024) Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression. American Journal of Respiratory and Critical Care Medicine. ISSN 1073-449X

Wasson, C., Dibb, S., Bryon, J. et al. (8 more authors) (2024) P27 Chloride intracellular channel 4 is a global regulator of type 1 interferon signalling in systemic sclerosis skin. British Journal of Dermatology, 190 (6). e91-e92. ISSN 0007-0963

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Kakkar, V., Di Donato, S. et al. (13 more authors) (2024) Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open, 10 (1). e003216. ISSN 2056-5933

Hughes, M. orcid.org/0000-0003-3361-4909, Di Donato, S. orcid.org/0000-0003-1256-0761, Gjeloshi, K. et al. (9 more authors) (2023) MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study. The Lancet Rheumatology, 5 (10). e611-e621. ISSN 2665-9913

De Lorenzis, E., Rindone, A., Di Donato, S. et al. (1 more author) (2023) Circulating extracellular vesicles in the context of interstitial lung disease related to systemic sclerosis: A scoping literature review. Autoimmunity Reviews, 22 (9). 103401. ISSN 1568-9972

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Wasson, C.W. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2023) Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives. Journal of Scleroderma and Related Disorders. ISSN 2397-1983

Denton, C.P. orcid.org/0000-0003-3975-8938, De Lorenzis, E., Roblin, E. et al. (27 more authors) (2023) Management of systemic sclerosis: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 7 (1). rkad022. ISSN 2514-1775

Conference or Workshop Item

DI Donato, S., Ross, R., Karanth, R. et al. (6 more authors) (2024) OP0314 Interferon score as a novel trial enrichment tool to predict clinical outcomes in patients with limited cutaneous systemic sclerosis. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

De Lorenzis, E., Natalello, G., Di Donato, S. et al. (6 more authors) (2023) AB0841 concordance and prognostic relevance of different definitions of systemic sclerosis interstitial lung disease progression. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (13 more authors) (2023) AB0881 clinical trajectories of multifactorial hand function deterioration in systemic sclerosis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 971.

Hughes, M., Di Donato, S., Gjeloshi, K. et al. (9 more authors) (2023) MRI digital artery volume index (DAVIX©) as quantitative, continuous imaging outcome measure of vascular disease in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 1018.

Di Donato, S., Hughes, M., Geloshi, K. et al. (6 more authors) (2023) P156 Evidence of Type I interferon activation during vascular manifestations of systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (4 more authors) (2023) P159 Clinical trajectories and predictors of hand function deterioration in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) OA28 CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis: rationale for a biological target driven basket trial across disease subsets. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Kakkar, V., Ross, R. et al. (11 more authors) (2022) POS0876 Serum Interferon Score Predicts Severity Of Patient Reported Hand Disability In Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 733-734.